ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

4 API Suppliers, 1 CEP/COS, 1 NDC API, 6 VMF, 3 Listed Suppliers

4 API Suppliers
1 CEP/COS
1 NDC API
6 VMF
3 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

7 FDF Dossiers, 6 Canada, 1 Listed Dossiers

7 FDF Dossiers
6 Canada
1 Listed Dossiers

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 1 DKSH, 1 Gangwal Healthcare, 1 Aeon Procare

relatedExcipients
4 SPI Pharma
1 DKSH
1 Gangwal Healthcare
1 Aeon Procare

EXCIPIENTS BY APPLICATIONS

5 Direct Compression, 3 Fillers, Diluents & Binders, 3 Chewable & Orodispersible Aids, 2 Taste Masking, 1 Co-Processed Excipients

excipientsByApplications
5 Direct Compression
3 Fillers, Diluents & Binders
3 Chewable & Orodispersible Aids
2 Taste Masking
1 Co-Processed Excipients

MARKET PLACE

4 APIs

marketPlace
4 APIs

PATENTS & EXCLUSIVITIES

3 Health Canada Patents

patents
3 Health Canada Patents

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

14EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 1405-53-4

Molecular Formula

C₄₆H₈₀NO₂₁P

Molecular Weight

1014.1 g/mol

InChI Key

NBOODGNJLRRJNA-ZIRPUHSHSA-N

1 2D Structure

Tylosin Phosphate

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

2-[(4R,5S,6S,7R,9R,11E,13Z,15R,16R)-6-[(2R,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-5,9,13-trimethyl-2,10-dioxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde;phosphoric acid

2.1.2 InChI

InChI=1S/C46H77NO17.H3O4P/c1-13-33-30(22-58-45-42(57-12)41(56-11)37(52)26(5)60-45)18-23(2)14-15-31(49)24(3)19-29(16-17-48)39(25(4)32(50)20-34(51)62-33)64-44-38(53)36(47(9)10)40(27(6)61-44)63-35-21-46(8,55)43(54)28(7)59-35;1-5(2,3)4/h14-15,17-18,24-30,32-33,35-45,50,52-55H,13,16,19-22H2,1-12H3;(H3,1,2,3,4)/b15-14+,23-18-;/t24-,25+,26-,27-,28+,29+,30-,32-,33-,35+,36-,37-,38-,39-,40-,41-,42-,43+,44+,45-,46-;/m1./s1

2.1.3 InChI Key

NBOODGNJLRRJNA-ZIRPUHSHSA-N

2.1.4 Canonical SMILES

CCC1C(C=C(C=CC(=O)C(CC(C(C(C(CC(=O)O1)O)C)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)C)COC4C(C(C(C(O4)C)O)OC)OC.OP(=O)(O)O

2.1.5 Isomeric SMILES

CC[C@@H]1[C@H](/C=C(\C=C\C(=O)[C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)N(C)C)O)CC=O)C)/C)CO[C@H]4[C@@H]([C@@H]([C@@H]([C@H](O4)C)O)OC)OC.OP(=O)(O)O

2.2 Synonyms

2.2.1 MeSH Synonyms

1. Farmazin Tb

2. Pharmasin Tb

3. Tylosin Phosphate And Bentonite Drug Combination

2.2.2 Depositor-Supplied Synonyms

1. 1405-53-4

2.3 Create Date

2013-05-17

3 Chemical and Physical Properties

Molecular Formula	C₄₆H₈₀NO₂₁P
Molecular Weight	1014.1 g/mol
Hydrogen Bond Donor Count	8
Hydrogen Bond Acceptor Count	22
Rotatable Bond Count	13
Exact Mass	1013.49604556 g/mol
Monoisotopic Mass	1013.49604556 g/mol
Topological Polar Surface Area	316 Å²
Heavy Atom Count	69
Formal Charge	0
Complexity	1610
Isotope Atom Count	0
Defined Atom Stereocenter Count	21
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	2
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2